User contributions for UmaMaveli
Jump to navigation
Jump to search
8 October 2020
- 03:4403:44, 8 October 2020 diff hist +37 Revefenacin →How is it supplied
- 03:4403:44, 8 October 2020 diff hist +292 Revefenacin →Clinical Studies
- 03:3803:38, 8 October 2020 diff hist +178 Revefenacin →IV Compatibility
7 October 2020
- 21:2221:22, 7 October 2020 diff hist +90 Revefenacin →Adverse Reactions
- 21:2021:20, 7 October 2020 diff hist +202 Revefenacin →Adult Indications and Dosage
- 21:1721:17, 7 October 2020 diff hist +9 Revefenacin →Brand Names
- 21:1621:16, 7 October 2020 diff hist +367 Revefenacin No edit summary
11 August 2020
- 05:2705:27, 11 August 2020 diff hist +1 Gilteritinib →Use in Specific Populations
- 05:2405:24, 11 August 2020 diff hist −2 Gilteritinib →Clinical Studies
- 05:2405:24, 11 August 2020 diff hist +499 Gilteritinib →Clinical Studies
- 04:2804:28, 11 August 2020 diff hist +74 Gilteritinib →Drug Interactions
- 04:2504:25, 11 August 2020 diff hist +90 Gilteritinib →Clinical Studies
- 03:5903:59, 11 August 2020 diff hist +58 Gilteritinib →Contradictions
- 03:5603:56, 11 August 2020 diff hist +99 Gilteritinib →Pediatric Indications and Dosage
- 03:5403:54, 11 August 2020 diff hist +137 Gilteritinib →How is it Supplied
- 00:4700:47, 11 August 2020 diff hist +152 Gilteritinib →Precautions with Alcohol
- 00:4200:42, 11 August 2020 diff hist +348 Gilteritinib →Pharmacology
5 August 2020
- 17:4017:40, 5 August 2020 diff hist +87 Gilteritinib →IV Compatibility
- 17:3617:36, 5 August 2020 diff hist −178 User:UmaMaveli No edit summary current
- 17:3617:36, 5 August 2020 diff hist +64 Gilteritinib →Names of Drugs that Look Alike
- 17:2917:29, 5 August 2020 diff hist +10 Gilteritinib →Brand Names
- 17:2517:25, 5 August 2020 diff hist +2 Gilteritinib →Distribution
- 17:2417:24, 5 August 2020 diff hist +530 Gilteritinib →Adult Indications and Dosage
- 17:0217:02, 5 August 2020 diff hist −5 Gilteritinib →Adverse Reactions
- 17:0117:01, 5 August 2020 diff hist −2 Gilteritinib →Side Effects
- 17:0117:01, 5 August 2020 diff hist +614 Gilteritinib →Adverse Reactions
- 16:4716:47, 5 August 2020 diff hist +4 Gilteritinib →Adverse Reactions
- 16:4516:45, 5 August 2020 diff hist +126 Gilteritinib No edit summary Tag: Visual edit
4 August 2020
- 23:1323:13, 4 August 2020 diff hist +459 Gilteritinib No edit summary
- 23:0823:08, 4 August 2020 diff hist +14 Gilteritinib No edit summary
14 July 2020
- 20:4120:41, 14 July 2020 diff hist −342 Gilteritinib Replaced content with "__NOTOC__ {{CMG}} {{AE}}" Tag: Replaced
- 20:1220:12, 14 July 2020 diff hist +342 Gilteritinib I wrote down the structure of the page Tag: Visual edit
13 July 2020
- 18:0818:08, 13 July 2020 diff hist +4 Substance abuse →Pathophysiology
- 18:0718:07, 13 July 2020 diff hist +4 Substance abuse →Secondary Prevention
- 18:0618:06, 13 July 2020 diff hist +9 Substance abuse →Primary Prevention
- 18:0518:05, 13 July 2020 diff hist −8 Substance abuse →Surgery
- 18:0418:04, 13 July 2020 diff hist −16 Substance abuse →Medical Therapy
- 18:0218:02, 13 July 2020 diff hist +2 Substance abuse →Laboratory Findings
- 18:0118:01, 13 July 2020 diff hist +2 Substance abuse →Physical Examination
- 18:0018:00, 13 July 2020 diff hist −3 Substance abuse →History and Symptoms
- 17:5917:59, 13 July 2020 diff hist +6 Substance abuse →History and Symptoms
- 17:5817:58, 13 July 2020 diff hist −1 Substance abuse →Diagnostic Study of Choice
- 17:5617:56, 13 July 2020 diff hist +2 Substance abuse →Natural History, Complications, and Prognosis
- 17:5517:55, 13 July 2020 diff hist −186 Substance abuse →Screening
- 17:5317:53, 13 July 2020 diff hist −2 Substance abuse →Risk Factors
- 17:5117:51, 13 July 2020 diff hist +1 Substance abuse →Causes
- 17:4417:44, 13 July 2020 diff hist −1 Substance abuse →Classification
- 17:4317:43, 13 July 2020 diff hist −7 Substance abuse →Historical Perspective
- 17:4317:43, 13 July 2020 diff hist +1 Hyperimmunoglobulinemia D with recurrent fever →Epidemiology and Demographics
11 July 2020
- 20:4620:46, 11 July 2020 diff hist +195 Substance abuse →Screening